SCHEMBL4256337

SCHEMBL4256337

C=CCOC(=O)Nc1nc(C(O)C(=O)O)cs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.46
CSNK2A1 P68400 1/20 0.46
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CASP1 P29466 7/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
GSTO1 P78417 1/20 0.35
MAPT P10636 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 2/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13609562 0.88 MAPK1 (0.42) CSNK2A2CSNK2A1MEN1KMT2ATSHR
SCHEMBL4259417 0.87 CSNK2A2 (0.44) CSNK2A2CSNK2A1MEN1KMT2ACASP1
SCHEMBL13609547 0.85 CSNK2A2 (0.43) CSNK2A2CSNK2A1MEN1KMT2ACASP1
SCHEMBL13609558 0.84 CSNK2A2 (0.41) CSNK2A2CSNK2A1MEN1KMT2ACASP1
SCHEMBL13609563 0.83 CSNK2A2 (0.40) CSNK2A2CSNK2A1MEN1KMT2ATSHR
SCHEMBL9075797 0.81 PDE5A (0.37) KMT2ATSHRMAPK1MAPTNPC1
SCHEMBL13609548 0.81 CSNK2A2 (0.40) CSNK2A2CSNK2A1MEN1KMT2ATSHR
SCHEMBL4255385 0.80 L3MBTL1 (0.54) CSNK2A2CSNK2A1MEN1KMT2ATSHR
SCHEMBL27712731 0.80 CSNK2A2 (0.39) CSNK2A2CSNK2A1MEN1KMT2ATSHR
SCHEMBL4255127 0.79 NPC1 (0.42) CSNK2A2CSNK2A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281142-A1 THIAZOLE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-12 US disclosed
EP-1921074-A1 THIAZOLE DERIVATIVE Astellas Pharma Inc. (JP) 2008-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281142-A1 THIAZOLE DERIVATIVE GK, GCKR, AK2 CSNK2A2 1200/4885CSNK2A1 1582/4885MEN1 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.